A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Shahneen K Sandhu Fran Balkwill |
| Publication date | February 6, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |